The moderating effects of social support and depressive symptoms on pain among elderly multimorbid patients-data from the multicentre, prospective, observational cohort study MultiCare.


Journal

Aging & mental health
ISSN: 1364-6915
Titre abrégé: Aging Ment Health
Pays: England
ID NLM: 9705773

Informations de publication

Date de publication:
Apr 2022
Historique:
pubmed: 6 5 2021
medline: 26 4 2022
entrez: 5 5 2021
Statut: ppublish

Résumé

Depressive symptoms and chronic pain are common among patients with multimorbidity creating a complex medical condition for both the patient and the general practitioner. Perceived social support may function as a protective measure. To examine the impact of perceived social support as a potential moderator between depressive symptoms and pain intensity and pain disability in daily activities in multimorbid patients aged 75+. Data from 3,189 patients of the German longitudinal cohort study MultiCare were obtained at baseline and follow-ups during 5 years. Multilevel linear mixed-effects analyses were conducted for pain intensity (model 1) and pain disability in daily activities (model 2). The interaction term social support by depression score was included to test for moderation. The interaction between social support and depressive symptoms was significantly associated with the pain intensity score 0.41 (SE=.17; 95-CI[.08;.74]) but not with the pain disability score 0.35 (SE=.19; 95-CI[-.01;.72]). Additionally, men and individuals with medium or higher educational level showed reduced pain intensity and disability scores. Pain disability scores increased with age and depressive symptoms. Increased pain scores were also found for body mass index and burden of multimorbidity. Perceived social support amplified the association of depressive symptoms on pain intensity and did not show a protective function. The high scores of perceived social support among the participants may point to the practice of secondary gain due to the patients immense health burden.

Identifiants

pubmed: 33949271
doi: 10.1080/13607863.2021.1916882
doi:

Types de publication

Journal Article Multicenter Study Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

803-809

Auteurs

Tina Mallon (T)

Department of Primary Medical Care, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Ingmar Schäfer (I)

Department of Primary Medical Care, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Angela Fuchs (A)

Institute of General Practice, University Düsseldorf, Düsseldorf, Germany.

Jochen Gensichen (J)

Institute of General Practice and Family Medicine, University Hospital of Ludwig-Maximilians-University Munich, Munich, Germany.

Wolfgang Maier (W)

Department of Psychiatry and Psychotherapy, University Bonn, Bonn, Germany.

Steffi Riedel-Heller (S)

Institute for Social Medicine, Occupational Health and Public Health, University Leipzig, Leipzig, Germany.

Hans-Helmut König (HH)

Department of Health Economics and Health Services Research, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Karola Mergenthal (K)

Institute of General Practice, Goethe University Frankfurt Am Main, Frankfurt Am Main, Germany.

Gerhard Schön (G)

Department of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Karl Wegscheider (K)

Department of Medical Biometry and Epidemiology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Siegfried Weyerer (S)

Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Birgitt Wiese (B)

Institute of General Practice, WG Medical Statistics and IT-Infrastructure, Hannover Medical School, Hannover, Germany.

Hendrik van den Bussche (H)

Department of Primary Medical Care, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Martin Scherer (M)

Department of Primary Medical Care, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH